Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming A... (drated prior to use of ZOMETA and loop d...)

Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting

Date:12/2/2009

drated prior to use of ZOMETA and loop diuretics (if applicable). Loop diuretics should be used with caution in combination with ZOMETA to avoid hypocalcemia. ZOMETA should be used with caution with other nephrotoxic drugs. Carefully monitor serum calcium, phosphate, magnesium, and serum creatinine following initiation of ZOMETA. Short-term supplemental therapy may be necessary.

In patients with impaired renal function, the risk of adverse reactions (especially renal adverse reactions) may be greater. Consider individual patient risk/benefit profile before starting ZOMETA therapy in HCM patients with severe renal impairment. ZOMETA treatment is not recommended in patients with bone metastases with severe renal impairment. Preexisting renal insufficiency and multiple cycles of ZOMETA and other bisphosphonates are risk factors for subsequent renal deterioration with ZOMETA. Do not use doses greater than 4 mg. ZOMETA should be administered by IV infusion over no less than 15 minutes. Monitor serum creatinine before each dose.

Osteonecrosis of the jaw (ONJ) has been reported predominantly in cancer patients treated with intravenous bisphosphonates, including ZOMETA. Many of these patients were also receiving chemotherapy and corticosteroids, which may be risk factors for ONJ. Postmarketing experience and the literature suggest a greater frequency of reports of ONJ based on tumor type (advanced breast cancer, multiple myeloma) and dental status (dental extraction, periodontal disease, local trauma, including poorly fitting dentures). Many reports of ONJ involved patients with signs of local infection, including osteomyelitis. Cancer patients should maintain good oral hygiene and should have a dental examination with preventive dentistry prior to treatment with bisphosphonates. While on treatment, these patients should avoid invasive dental procedures, if possible, as recovery may be prolonged. For patients who develop ONJ while on bisphosp
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes

Post Your Comments:

(Date:6/19/2013)... 19, 2013 Voices Against Brain Cancer ... for brain cancer, today announced that it has awarded ... the clinical investigation of Toca 511 & Toca FC ... brain cancer (Grade 3 or Grade 4). Tocagen is ... advanced cancer, with an initial focus on brain cancer. ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, ... American healthcare company providing services in ... Family Healthcare, a network of private hospitals and ... of its Beijing United Family Rehabilitation Hospital ("BJU ... of the United Family Healthcare ("UFH") network. On ...

(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...

Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2 Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5 New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2

[0] Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer [0] Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital [0] New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research

... Gene Expression in Female and Male Patients Presented at ASCO ... (Nasdaq: GHDX ) today announced results from a ... type DX(R) breast cancer test in a large number ... guide treatment with chemotherapy. The results, which will be presented ...

... ET Today CORAL GABLES, Fla., May 29 ... today announced top-line results from its U.S. Phase II ... from the trial showed that CPP-109 did not demonstrate ... significantly larger proportion of CPP-109-treated subjects than placebo-treated subjects ...

Cached Medicine Technology:Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2 Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3 Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4 Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5 Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 2 Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 3 Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 4

Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction

(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Alternatives, ... permits some patients to quit using drugs while allowing ... Adi Jaffe, the founders of Alternatives, believe that abstinence-only ... before they enter treatment and that this approach hurts ... million people in the United States need treatment for ...

(Date:6/19/2013)... St. Louis, MO (PRWEB) June 19, 2013 ... solutions organization, partnered with ARAMARK Healthcare Technologies to ... equipment management plan with savings of more than ... repair and maintenance service expenditures. , “Driving economies ... the top medical equipment management challenges facing multi-site ...

(Date:6/19/2013)... a world-leading provider of scientific, technical and medical ... of the National Osteoporosis Guideline Group (NOGG) Update ... postmenopausal women and older men in the journal ... Maturitas , the original guidelines have been ... an additional focus on the management of glucocorticoid-induced ...

(Date:6/19/2013)... Mass. (PRWEB) June 19, 2013 ... security solutions, today announced that Imprivata OneSign ® ... KLAS® 2013 Mid-Term Performance Review: Software & Services report ... KLAS laud Imprivata on the superior performance of its ... support, and they indicate that Imprivata is integral to ...

(Date:6/19/2013)... According to Transparency Market Research “Endoscopy devices Market ... Forecast, 2011 – 2017,” the global endoscopy devices market ... and is expected to reach USD 10.8 billion by ... to 2017. Flexible endoscopes formed the largest category in ... for the year 2011. , Related Report : Medical ...

Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2 Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3 Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2 Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2 Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3 Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2 Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3

[0] Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment [0] Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program [0] Maturitas publishes 2013 update on diagnosis and management of osteoporosis [0] Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review [0] Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research

... These classifications can help explain different outcomes for women ... (HealthDay News) -- Classification of breast cancer into subtypes ... uses only three genes, U.S. researchers say. , They ... 4,600 breast cancer patients and six classification models. , ...

... as epigenetic modifications, regulate the activity of many ... often inactivates important cellular growth brakes. Therefore, this ... major cause of uncontrolled division of cancer cells. ... methylation. Unlike changes in the blueprint ...

... muffin tops and stomach tires white fat tissue forms ... energy. Exactly the opposite happens in brown fat tissue: Instead ... dismay of many people, adults have only small amounts of ... have lots of it in their bodies where it serves ...

... ... McNeil Consumer Healthcare recall have drafted a downloadable letter intended to be ... details unanswered questions of concerned parents as McNeil Consumer Healthcare and the ... Tylenol, Motrn, Zyrtec and Benadryl. This letter is being made public ...

... ... hospital knows just how stressful and time consuming it is to provide updates ... of a new iPhone tool called howsthepatient, it will now be possible to ... who you want to communicate with, share health alerts, send pictures, and provide ...

... ... present a no-holds-barred look at Costa Rica and other countries in order to answer the ... , ... -- While Costa Rica has long been the investment darling of Central America when it ...

Cached Medicine News:Health News:Simple Test May Identify Breast Cancer Subtypes 2 Health News:Fatty acid to enhance anticancer drug 2 Health News:Slimming aid from the cell laboratory? 2 Health News:Facebook Group for McNeil Product Recall Organizes Letter Writing Campaign – Urges Concerned Parents to Contact House of Representatives and Senators 2 Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 2 Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 3 Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 4 Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 2 Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 3

Simple Test May Identify Breast Cancer Subtypes Fatty acid to enhance anticancer drug Slimming aid from the cell laboratory?Facebook Group for McNeil Product Recall Organizes Letter Writing Campaign – Urges Concerned Parents to Contact House of Representatives and Senators New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate?

Malaria Pf. Assay Range...

An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....

192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection....

Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...

Medicine Products:

Malaria Pf. Assay Range PALUTOP+4 Malaria Antigen CELISA Malaria Device / Strip (3 line, PAN-pLDH, P.f.-HRP2)